How a Medical Recoding May Limit Cancer Patients’ Options for Breast Reconstruction
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
A Catch-22 for Clinics: State Bans Limit Abortion Counseling. Federal Title X Rules Require It.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
End of Covid Emergency Will Usher in Changes Across the US Health System
The May 11 expiration of the federal government’s pandemic emergency declaration will affect patient care across a broad range of settings, including telemedicine, hospitals, and nursing homes.
Idaho Dropped Thousands From Medicaid in the Pandemic’s First Years
The removals, detailed in emails between state and federal health officials, hinged on disagreements over how states could disenroll people during the public health emergency. Consumer advocates fear the alleged violation signals the mess to come on April 1, when the pandemic-era Medicaid coverage mandate ends.
Why Medicaid Expansion Ballots May Hit a Dead End After a Fleeting Victory in South Dakota
Since 2017, Medicaid expansion has been adopted in seven states where a question was placed directly on the ballot. But campaign leaders say that strategy may not work in Florida and Wyoming, where Republican opposition remains strong.
Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?
Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
Cinco cosas que hay que saber sobre el aborto ahora que la Corte Suprema anuló Roe vs. Wade
Con esta decisión, los estados tienen la capacidad de establecer sus propias restricciones, por lo que el lugar en el que viven las personas determinará su nivel de acceso al aborto.
‘It’s Not a Haven’: With Limited Capacity for Abortion Care, Minnesota Clinics Brace for Influx
In Minnesota, where abortion rights are protected by the state’s constitution, legal doesn’t necessarily mean accessible. The state has just eight clinics that provide abortions, and both providers and advocates say resources available aren’t enough to meet demand as nearby states reduce abortion access.
Five Things to Know Now That the Supreme Court Has Overturned Roe v. Wade
By undoing that landmark decision, the law of the land since 1973, the court has empowered states to set their own abortion restrictions — so where people live will determine their level of access.
Patients’ Perilous Months-Long Waiting for Medicaid Coverage Is a Sign of What’s to Come
The pandemic crisis has overwhelmed understaffed state Medicaid agencies, already delaying access to the insurance program in Missouri. As the public health emergency ends, low-income people nationwide could find it even harder to have coverage.
‘The Danger Is Still There’ ― As Omicron Lurks, Native Americans Are Wary of Boosters
Federal data shows that vaccination rates for American Indians and Alaska Natives were some of the highest in the nation, but tribes say resistance has slowed efforts to boost members.
Big Pharma Is Betting on Bigger Political Ambitions From Sen. Tim Scott
The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.
Biden Pledges Better Nursing Home Care, but He Likely Won’t Fast-Track It
CMS chief Chiquita Brooks-LaSure says the agency reserves its power to quickly institute new regulations for “absolute emergencies.” On staffing, nursing home residents might need to wait years to see any real change.
Why Millions on Medicaid Are at Risk of Losing Coverage in the Months Ahead
State Medicaid agencies for months have been preparing for the end of a federal mandate that has prevented states from removing people from the safety-net program during the pandemic.
At Nursing Homes, Long Waits for Results Render Covid Tests ‘Useless’
As omicron surges, more nursing homes are facing a double whammy: Lab tests are taking too long, and fast antigen tests are in short supply.
As Omicron Surges, Effort to Vaccinate Young Children Stalls
Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming, especially against the backdrop of record numbers of cases and pediatric hospitalizations.
Hospitales le piden a Santa suministros: falta de todo, desde sillas de ruedas hasta jeringas
En otra consecuencia de la crisis de la cadena de suministro global, hospitales que gestionan los picos de casos de covid durante las Fiestas y a todos sus otros pacientes se están quedando sin suministros básicos para atenderlos
Never Mind Toys, It’s Time to Ask Santa for Crutches and Catheters
As hospitals juggle holiday covid surges and all their other patients, the global supply chain crisis has left them short of critical supplies.
Why You Can’t Find Cheap At-Home Covid Tests
You probably won’t be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.